Clinical Trials Browser

Anatomic Stage III Breast Cancer AJCC v8

Breast Neoplasms

Brain Neoplasms, Neoplasm Metastasis

Breast Neoplasms, Neoplasm Metastasis

Prostatic Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Renal Cell

Anatomic Stage IV Breast Cancer AJCC v8

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

Endometrial Neoplasms

Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms

Breast Neoplasms

Recurrence, Endometrial Neoplasms

Adenocarcinoma of Endometrium

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Glioblastoma, Glioma

Malignant Neoplasms of Female Genital Organs

Breast Neoplasms, Neoplasm, Residual

Breast Neoplasms

Liver Metastases From Colorectal Cancer (mCRC)

Prostatic Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Endometrial Neoplasms

Brain Neoplasms

Unilateral Breast Neoplasms

ER-Positive Breast Cancer

Neoplasm Metastasis

Clinical Trials

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

FAIM

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer

UPLIFT

EVOLVE-BDT

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

TAPUR

EndoMAP

ABBICAR

Clinical and P

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer

I-SPY

Abemaciclib in Newly Diagnosed Meningioma Patients

CARABELA

Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients

Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma

MiRaDoR

VIOLET

Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver Metastases Cancer

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer

Abemaciclib With or Without Atezolizumab for mCRPC

Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer

DISCORDANT

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

ALPINE: Maintenance Letrozole/Abemaciclib

Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases

Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer

GERTRUDE